| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.062 | 0.8 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |